Follow
Nabihah Tayob
Nabihah Tayob
Dana-Farber Cancer Institute
Verified email at ds.dfci.harvard.edu
Title
Cited by
Cited by
Year
Risk of pancreatic cancer in families with Lynch syndrome
F Kastrinos, B Mukherjee, N Tayob, F Wang, J Sparr, VM Raymond, ...
Jama 302 (16), 1790-1795, 2009
6052009
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
E Stoffel, B Mukherjee, VM Raymond, N Tayob, F Kastrinos, J Sparr, ...
Gastroenterology 137 (5), 1621-1627, 2009
4382009
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
MLK Han, Y Zhou, S Murray, N Tayob, I Noth, VN Lama, BB Moore, ...
The Lancet Respiratory Medicine 2 (7), 548-556, 2014
3762014
Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis
PK Naik, PD Bozyk, JK Bentley, AP Popova, CM Birch, CA Wilke, CD Fry, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 303 …, 2012
2842012
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy
MLK Han, N Tayob, S Murray, MT Dransfield, G Washko, PD Scanlon, ...
American journal of respiratory and critical care medicine 189 (12), 1503-1508, 2014
2082014
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
SL Schmidt, AM Nambiar, N Tayob, B Sundaram, MK Han, BH Gross, ...
European Respiratory Journal 38 (1), 176-183, 2011
1692011
Predicting pulmonary fibrosis disease course from past trends in pulmonary function
SL Schmidt, N Tayob, MK Han, C Zappala, D Kervitsky, S Murray, ...
Chest 145 (3), 579-585, 2014
1222014
Prognostic and biologic significance of ERBB2-low expression in early-stage breast cancer
P Tarantino, Q Jin, N Tayob, RM Jeselsohn, SJ Schnitt, J Vincuilla, ...
JAMA oncology 8 (8), 1177-1183, 2022
1102022
Adjuvant trastuzumab emtansine versus paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT): a randomized clinical trial
SM Tolaney, N Tayob, C Dang, DA Yardley, SJ Isakoff, V Valero, ...
Journal of Clinical Oncology 39 (21), 2375-2385, 2021
1032021
Phase II study of the WEE1 inhibitor adavosertib in recurrent uterine serous carcinoma
JF Liu, N Xiong, SM Campos, AA Wright, C Krasner, S Schumer, ...
Journal of Clinical Oncology 39 (14), 1531-1539, 2021
1032021
International Liver Cancer Association (ILCA) white paper on biomarker development for hepatocellular carcinoma
AG Singal, Y Hoshida, DJ Pinato, J Marrero, JC Nault, V Paradis, N Tayob, ...
Gastroenterology 160 (7), 2572-2584, 2021
962021
Idiopathic pulmonary fibrosis: gender-age-physiology index stage for predicting future lung function decline
ML Salisbury, M Xia, Y Zhou, S Murray, N Tayob, KK Brown, AU Wells, ...
Chest 149 (2), 491-498, 2016
912016
Improved detection of hepatocellular carcinoma by using a longitudinal alpha-fetoprotein screening algorithm
N Tayob, ASF Lok, KA Do, Z Feng
Clinical gastroenterology and hepatology 14 (3), 469-475. e2, 2016
882016
The performance of AFP, AFP-3, DCP as biomarkers for detection of hepatocellular carcinoma (HCC): a phase 3 biomarker study in the United States
N Tayob, F Kanwal, A Alsarraj, R Hernaez, HB El-Serag
Clinical Gastroenterology and Hepatology 21 (2), 415-423. e4, 2023
772023
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
AG Singal, N Tayob, A Mehta, JA Marrero, H El‐Serag, Q Jin, ...
Hepatology 75 (3), 541-549, 2022
752022
Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa
P Moodley, NS Shah, N Tayob, C Connolly, N Zetola, N Gandhi, ...
PloS one 6 (5), e17513, 2011
502011
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
ND Parikh, N Tayob, AG Singal
Journal of hepatology 78 (1), 207-216, 2023
462023
The impact of COVID-19 on clinical trial execution at the Dana-Farber Cancer Institute
SM Tolaney, CA Lydon, T Li, J Dai, A Standring, KA Legor, CM Caparrotta, ...
JNCI: Journal of the National Cancer Institute 113 (11), 1453-1459, 2021
442021
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial
SM Tolaney, P Tarantino, N Graham, N Tayob, L Parč, G Villacampa, ...
The Lancet Oncology 24 (3), 273-285, 2023
422023
Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases
DB Nelson, N Tayob, KG Mitchell, AM Correa, WL Hofstetter, B Sepesi, ...
The Journal of thoracic and cardiovascular surgery 157 (4), 1648-1655, 2019
412019
The system can't perform the operation now. Try again later.
Articles 1–20